- Home
- NL vs ALDX Comparison
NL vs ALDX Comparison
Compare NL & ALDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NL | ALDX |
|---|---|---|
| Founded | 1891 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 283.9M | 293.0M |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | NL | ALDX |
|---|---|---|
| Price | $5.62 | $4.56 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $9.50 |
| AVG Volume (30 Days) | 26.0K | ★ 953.0K |
| Earning Date | 11-06-2025 | 11-05-2025 |
| Dividend Yield | ★ 9.91% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.20 | N/A |
| Revenue | ★ $159,004,000.00 | N/A |
| Revenue This Year | $15.75 | N/A |
| Revenue Next Year | $2.44 | $36.25 |
| P/E Ratio | $29.18 | ★ N/A |
| Revenue Growth | ★ 5.52 | N/A |
| 52 Week Low | $5.04 | $1.14 |
| 52 Week High | $9.42 | $7.20 |
Technical Indicators
Market Signals| Indicator | NL | ALDX |
|---|---|---|
| Relative Strength Index (RSI) | 52.81 | 39.04 |
| Support Level | $5.33 | $4.67 |
| Resistance Level | $5.74 | $5.04 |
| Average True Range (ATR) | 0.24 | 0.29 |
| MACD | 0.04 | -0.05 |
| Stochastic Oscillator | 80.39 | 3.42 |
Price Performance
Historical ComparisonAbout NL NL Industries Inc.
NL Industries Inc is a holding company that operates in the component products industry. Through its subsidiary, it manufactures engineered components that are sold to a range of industries, including recreational transportation, postal, office and institutional furniture, cabinetry, tool storage, healthcare, gas stations and vending equipment. It also produces a precision ball bearing slide, security products, and ergonomic computer support systems. The company derives majority of its revenue from Europe.
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.